iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Get Free Report)’s share price traded down 1.3% during trading on Tuesday . The company traded as low as $22.76 and last traded at $22.86. 48,876 shares changed hands during mid-day trading, an increase of 38% from the average session volume of 35,439 shares. The stock had previously closed at $23.16.
iShares Genomics Immunology and Healthcare ETF Stock Performance
The business’s 50 day moving average is $23.63 and its 200 day moving average is $23.37. The stock has a market cap of $133.76 million, a price-to-earnings ratio of 2.29 and a beta of 1.14.
iShares Genomics Immunology and Healthcare ETF Company Profile
The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.
Featured Stories
- Five stocks we like better than iShares Genomics Immunology and Healthcare ETF
- What Are Dividends? Buy the Best Dividend Stocks
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- The 3 Best Fintech Stocks to Buy Now
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Using the MarketBeat Dividend Yield Calculator
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for iShares Genomics Immunology and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Genomics Immunology and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
